Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction

E-ISSN： 1399-0012|32|1|ctr.13156-ctr.13156

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.32, Iss.1, 2018-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of HMG-CoA Reductase Inhibitors (Statins) on Bone Mineral Density

By Funkhouser H.L. Adera T. Adler R.A.

Journal of Clinical Densitometry, Vol. 5, Iss. 2, 2002-06 ,pp. : 151-158

Humana Press, Inc

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors: Is the Endothelium the Main Target?

Cardiology, Vol. 95, Iss. 1, 2001-05 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

The Use of Simvastatin, an HMG CoA Reductase Inhibitor, in Older Patients with Hypercholesterolemia and Atherosclerosis

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 1, 1990-01 ,pp. : 10-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of HMG‐CoA reductase inhibitors on the incidence of polyomavirus‐associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 536-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors Reduce Nicotine-Induced Expression of Cellular Adhesion Molecules in Cultured Human Coronary Endothelial Cells

Journal of Vascular Research, Vol. 44, Iss. 6, 2007-07 ,pp. : 460-470

Karger

Access to resources Recommend Favorite